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Functional Interaction between Monoamine
Plasma Membrane Transporters and the Synaptic
PDZ Domain–Containing Protein PICK1
transporters (Ritz et al., 1987; Amara and Sonders,
1998), which results in elevation of extracellular trans-
mitter concentrations and alteration of mood and behav-
ior. The physiological contribution of monoamine trans-
porters to neural transmission has been suggested by
Gonzalo E. Torres,*k Wei-Dong Yao,*k
Amy R. Mohn,* Hui Quan,* Kyeong-Man Kim,*
Allan I. Levey,† Jeff Staudinger,‡
and Marc G. Caron*§
*Howard Hughes Medical Institute
Department of Cell Biology pharmacological studies and further substantiated by
genetic approaches. Deletion of monoamine transporterDuke University Medical Center
Durham, North Carolina 27710 genes leads to important neurochemical changes char-
acterized by enhanced extracellular transmitter levels†Department of Neurology
Emory University and reduced neuronal content (Giros et al., 1996; Bengel
et al., 1998; Jones et al., 1998a; Xu et al., 2000). TheseAtlanta, Georgia 30322
‡Department of Pharmacology, Toxicology, changes have significant biochemical and behavioral
consequences. Mice lacking the dopamine transporterand Therapeutics
The University of Kansas Medical Center (DAT) gene display hyperlocomotor activity and an al-
tered response to both cocaine and amphetamine (GirosKansas City, Kansas 66160
et al., 1996; Jones et al., 1998b), whereas the targeted
disruption of the gene encoding the norepinephrine
transporter (NET) produces sensitization to cocaine andSummary
amphetamine accompanied by dopamine D2/D3 recep-
tor supersensitivity (Xu et al., 2000).PDZ domain–containing proteins play an important
The three biogenic amine transporters—DAT, NET,role in the targeting and localization of synaptic mem-
and the serotonin transporter (SERT)—can be consid-brane proteins. Here, we report an interaction between
ered specific markers of dopaminergic, noradrenergic,the PDZ domain–containing protein PICK1 and mono-
and serotonergic neurons respectively, as they are ex-amine neurotransmitter transporters in vitro and in
pressed exclusively in cells that synthesize the cognatevivo. In dopaminergic neurons, PICK1 colocalizes with
neurotransmitter. To carry out their physiological roles,the dopamine transporter (DAT) and forms a stable
transporters must be further targeted to specialized do-protein complex. Coexpression of PICK1 with DAT in
mains at or near sites of presynaptic transmitter release.mammalian cells and neurons in culture results in col-
Immunoelectron microscopy studies using a highly se-ocalization of the two proteins in a cluster pattern and
lective DAT antiserum reveal that this protein predomi-an enhancement of DAT uptake activity through an
nantly localizes to distal dendrites and axons of nigro-increase in the number of plasma membrane DAT.
striatal dopaminergic neurons (Nirenberg et al., 1996;Deletion of the PDZ binding site at the carboxyl termi-
Hersch et al., 1997; Pickel and Chan, 1999). Recently,nus of DAT abolishes its association with PICK1 and
immunocytochemical studies demonstrated that SERTimpairs the localization of the transporter in neurons.
is found primarily in the axolemma outside synapticThese findings indicate a role for PDZ-mediated pro-
junctions (Zhou et al., 1998; Tao-Cheng and Zhou, 1999).tein interactions in the localization, expression, and
Interestingly, these studies also demonstrated that DATfunction of monoamine transporters.
and SERT are associated with intracellular compart-
ments, particularly membranes of tubulovesicular struc-Introduction
tures. Thus, these findings not only support the notion
that transporters for monoamines are strategicallyIn the CNS, plasma membrane transporters for biogenic
sorted to distal neural processes but also imply that aamines play a fundamental role in maintaining the physi-
recycling mechanism might exist to shuttle the trans-ological levels of dopamine, norepinephrine, and seroto-
porters between intracellular compartments and thenin in extracellular spaces (Jones et al., 1998a). These
plasma membrane.integral membrane proteins are responsible for the high-
At the cell membrane, the function of monoamineaffinity uptake of released transmitters into presynaptic
transporters can be regulated by multiple second mes-nerve terminals, thus controlling the strength and the
senger systems. This modulation occurs largely throughduration of synaptic activity. Clinically, agents that tar-
redistribution of the transporter proteins from the cellget monoamine transporters are widely used in the man-
surface rather than changes in the intrinsic transportagement of depression, obsessive–compulsive disor-
activity. The best-characterized effect is the downregu-der, and several other psychiatric conditions (Giros and
lation of transporter activity by protein kinase C (PKC)Caron, 1993; Amara and Kuhar, 1993; Barker and
activators, which has been extensively described in sev-Blakely, 1995). Moreover, drugs of abuse such as co-
eral systems including striatal synaptosomes and heter-caine and amphetamine exhibit their potent rewarding
ologous cells (Copeland et al., 1996; Qian et al., 1997;and reinforcing effects in part by acting at monoamine
Vaughan et al., 1997; Apparsundaram et al., 1998; Rama-
moorthy et al., 1998; Melikian and Buckley, 1999). Re-§ To whom correspondence should be addressed (e-mail: caron002@
cent evidence suggests that a clathrin-mediated, dy-mc.duke.edu).
k These authors contributed equally to this work. namin-dependent internalization process underlies the
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decrease in transporter activity due to PKC activation et al., 1999). To test the hypothesis that the PDZ domain
of PICK1 is responsible for the interaction with DAT, we(Daniels and Amara, 1999).
Despite extensive studies of monoamine transporters mutated PICK1 lysine and aspartate residues at posi-
tions 27 and 28, respectively, to alanine residues. Theseand their contribution to the regulation of neurotrans-
mission, little is known about putative accessory com- amino acids form part of the carboxylate binding loop
of the PDZ domain, which is believed to bind to the lastponents involved in monoamine transporter regulatory
mechanisms. Such potential interacting proteins might several residues at the carboxyl terminus of interacting
proteins (Doyle et al., 1996; Songyang et al., 1997). Ascontrol the subcellular localization of transporters or
alternatively modulate transporter function. In an effort shown in Figure 1B, the mutant PICK1K27A/D28A does
not associate with DAT in the yeast assay, indicatingto search for candidate proteins capable of interacting
with monoamine transporters, we performed a yeast that the PDZ domain of PICK1 is responsible for the
interaction with DAT.two-hybrid screening using the carboxy-terminal tail of
DAT and identified the synaptic protein PICK1. PICK1 A hallmark of most PDZ domain–mediated interac-
tions is the requirement of a consensus sequence lo-is a member of an emerging family of PDZ domain–
containing proteins that play an important role in the cated at the extreme carboxyl terminus of interacting
proteins. Class I PDZ domains bind to a carboxy-termi-targeting and clustering of several receptors and ion
channels (Kornau et al., 1997). Here, we show that DAT nal motif with the consensus sequence S/T-X-V/I (where
X is any amino acid), whereas class II PDZ domainsbinds, clusters, and colocalizes with PICK1 in vitro and
in vivo. In mammalian cells and neurons in culture, over- have a preference for the sequence `-X-` (where `
represents any hydrophobic residue; Songyang et al.,expression of PICK1 results in a significant enhance-
ment of DAT activity via a mechanism involving an 1997). Because the carboxyl terminus of DAT ends in
the sequence LKV, a putative class II PDZ binding site,increased expression of transporters at the cell mem-
brane. We further demonstrate that NET also specifically we sought to examine the involvement of this domain
in specific binding to PICK1. A series of DATC mutantsinteracts with PICK1 in HEK-293 cells and colocalizes
with PICK1 in cultured neurons of the noradrenergic were generated and tested for their ability to interact
with PICK1. Removal of the last four residues of DATClocus coeruleus. These interactions are mediated by the
PDZ domain of PICK1 and a PDZ recognition site located (W-L-K-V, DATC/W617*) completely disrupted PICK1
binding in yeast (Figure 1C). In addition, deletion of theat the carboxyl termini of these transporters. Deletion
of this motif in DAT impairs the targeting of the trans- carboxy-terminal valine (DATC/V620*) or addition of a
single amino acid to the carboxyl terminus of DATporter to neuronal processes. Thus, in addition to ion
channels and neurotransmitter receptors, monoamine (DATC/*621Y) abolished the association of DAT with
PICK1 (Figure 1C). These results indicate that the inter-transporters represent a novel class of synaptic proteins
that can be regulated by PDZ-mediated protein interac- action with PICK1 requires the intact free carboxyl termi-
nus of DAT and is consistent with the observation thattions to confer potential modulations on synaptic trans-
mission. PDZ domain–containing proteins bind to specific con-
sensus sequences found in the last three or four amino
acids of their target proteins. Moreover, our results iden-Results
tify a previously unappreciated class II PDZ binding mo-
tif located at the carboxyl terminus of DAT.Interaction of DAT and PICK1 in the Yeast
Two-Hybrid System
To search for DAT-interacting proteins, we used the Binding, Colocalization, and Clustering of DAT
and PICK1 in Mammalian Cellsentire carboxy-terminal domain of DAT (DATC) as a bait
to screen a human brain library using the yeast two- The association of PICK1 and DAT observed in the yeast
assay was further examined in mammalian cells byhybrid system. From the approximately 20 million trans-
formants screened with DATC, three positive clones coimmunoprecipitation experiments. Whole-cell lysates
were prepared from HEK-293 cells cotransfected withwere found to encode the entire open reading frame of
the human PICK1, a member of a large family of PDZ the full-length DAT and PICK1 cDNAs. We found that
.80% of cells were transfected with DAT or with DATdomain–containing proteins, previously identified be-
cause of its ability to interact with PKCa (Staudinger et and PICK1. Under cotransfection conditions, the per-
centage of cells expressing both proteins, most oftenal., 1995). To rule out the possibility of a false positive
interaction, we tested several control constructs in the in the same cells, was remarkably similar (data not
shown). As shown in Figure 1D, immunoblot analysisyeast two-hybrid system. Only transformants bearing
the bait plasmid pAS2.1-DATC and the prey plasmid indicated that DAT was coprecipitated with a PICK1
antibody only when both proteins were expressed inpGAD10-PICK1 were positive for the adenine phenotype
selection (Figure 1A). Furthermore, a protein containing HEK-293 cells. Conversely, PICK1 was coprecipitated
with the DAT antibody only when both proteins werethe entire amino-terminal domain of DAT (DATN) fused
to pAS2.1 failed to interact with PICK1, thus demonstra- coexpressed in cells, demonstrating that the association
is independent of which protein has initially been pulledting the specificity of the association between the car-
boxyl terminus of DAT and PICK1. down.
Since the in vitro yeast data indicates that the interac-PICK1 contains a single PDZ domain at the amino
terminus (Staudinger et al., 1995), which has recently tion between PICK1 and DAT involves a PDZ binding
site at the extreme carboxyl terminus of DAT, we rea-been shown to be essential for the binding, synaptic
colocalization, and clustering of AMPA receptors (Xia soned that a truncated transporter missing the last four
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Figure 1. Specific Association between PICK1
and DAT in Yeast and in HEK-293 Cells
(A) Yeast strain pG694a was cotransformed
with plasmids encoding the GAL4 DNA bind-
ing domain fused to the tail of DAT or the
GAL4 activation domain fused to PICK1. Pro-
tein–protein interaction was assayed by
growing the yeast on selective medium lack-
ing leucine, tryptophan, and adenine
(2L2W2A). The specificity of this interaction
was tested by cotransforming a series of con-
trol plasmids in the yeast assay.
(B) Mutation of the PDZ motif in PICK1 dis-
rupts the interaction with DATC.
(C) Mutational analysis of the carboxy-termi-
nal sequence of DAT reveals the importance
of the terminal sequence LKV for the binding
to PICK1.
(D) PICK1 coprecipitates with the full-length
DAT in transfected HEK-293 cells.
(E) A truncated DAT lacking the last four resi-
dues does not interact with PICK1 by coimmu-
noprecipitation in HEK-293 cells. Whole-cell
lysates from cells transfected with the indi-
cated cDNAs were used for immunoprecipi-
tation with the anti-PICK1 antibody or the
anti-DAT antibody. Proteins were transiently
expressed in HEK-293 cells by transfecting
the indicated pcDNA3 constructs for DAT,
PICK1, or DATW617*. Immunoprecipitates
were separated on 8% SDS-PAGE, blotted
onto nitrocellulose membranes, and probed
with specific antibodies as indicated. Identi-
cal samples were used to obtain total PICK1
and DAT by immunoprecipitation with the re-
spective antibodies.
residues (DATW617*) would not be able to associate and DAT with a DAT antibody raised against the second
extracellular loop of DAT (Ciliax et al., 1995). As shownwith PICK1. Indeed, in cells transfected with PICK1 and
the truncated DAT, immunoprecipitation with the anti- in Figure 2D, staining of fixed cells without permeabiliza-
tion with the extracellular anti-DAT antibody followedDAT antibody did not result in PICK1 coprecipitation
(Figure 1E). These results demonstrate that PICK1 and by permeabilization and staining for PICK1 reveals ex-
tensive colocalization and clustered distribution for boththe full-length transporter can physically associate in
mammalian cells and this association requires an intact signals. These results indicate that these clusters are
localized at the plasma membrane.PDZ recognition site at the carboxyl terminus of DAT.
The subcellular localization of DAT and PICK1was The specificity of cluster formation was examined with
the use of DAT mutants lacking the PICK1 binding sitenext examined in transfected HEK-293 cells with the
use of confocal immunofluorescence microscopy. DAT or a PICK1 mutant in which the PDZ domain has been
disrupted. Deletion of the entire carboxyl terminus ofand PICK1 displayed different distribution patterns
when expressed separately in HEK-293 cells. Cells ex- DAT results in a nonfunctional transporter (data not
shown) that is predominantly retained inside the cellpressing PICK1 alone exhibited diffuse staining through-
out the cytoplasm (Figure 2A), whereas in cells express- (Figure 3B). Both the colocalization and cluster forma-
tion were abolished in cells coexpressing PICK1 anding DAT alone, the transporter was localized both at the
cell surface and intracellularly (Figure 2B). We did not this truncated transporter (Figure 3B). In addition, no
cluster formation was detected when the PDZ interac-detect cross-reactivity between the PICK1 and DAT anti-
bodies (Figures 2A and 2B). When PICK1 and DAT were tion was disrupted by the removal of the PDZ binding
site from DAT (Figures 3C and 3D). These mutants showcoexpressed in HEK-293 cells, the distribution pattern
of each protein changed dramatically and overlapped a reduced cell membrane expression concomitant with
an increase in intracellular localization, suggesting thatalmost completely as revealed by the merging of confo-
cal immunofluorescence images (Figure 2C). In virtually the terminal PDZ binding site is important for the tar-
geting of the transporter to the cell membrane. Finally,all cells coexpressing DAT and PICK1, the two proteins
colocalized in cluster aggregates (Figure 2C). To assess mutation of the PDZ domain in PICK1 also results in the
lack of colocalization and cluster formation (Figure 3E).whether these clusters are located inside the cell or at
the cell membrane, we labeled cells coexpressing PICK1 These results demonstrate that both the PDZ binding
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Figure 2. Colocalization and Cluster Forma-
tion in HEK-293 Cells Coexpressing DAT and
PICK1
(A) HEK-293 cells transfected with PICK1
cDNA were labeled with a rabbit anti-PICK1
antibody and a FITC anti-rabbit secondary
antibody. In these cells, PICK1 is diffusely
distributed throughout the cytoplasm.
(B) Cells expressing DAT alone were labeled
with a rat anti-DAT antibody raised against
the intracellular amino terminus of DAT and
a Texas red anti-rat secondary antibody. The
transporter is found predominantly at the cell
membrane, with some detectable intracellu-
lar staining.
(C) Coexpression of PICK1 and DAT pro-
duces a redistribution of both proteins, which
colocalize in a cluster pattern as revealed by
double-labeling immunofluorescence.
(D) The clusters formed by DAT and PICK1
are localized to the plasma membrane as re-
vealed by the use of a rat anti-DAT antibody
raised against the second extracellular loop
of DAT. Fixed cells were stained with the anti-
DAT antibody, permeabilized, and stained
with the PICK1 antibody.
site in DAT and the PDZ domain of PICK1 are responsible pressed in HEK-293 cells or the affinity of [3H]CFT for
the transporter (Kd 5 7.5 6 0.83 nM and Bmax 5 6.2 6for the DAT-PICK1 clustering.
0.78 pmol/mg for cells expressing DAT versus Kd 5
7.4 6 0.45 nM and Bmax 5 4.8 6 0.69 pmol/mg for cells
Functional Consequences coexpressing DAT and PICK1; Figure 4B). These results
of the DAT-PICK1 Interaction indicate that the enhancement of DAT activity by PICK1
Next, we examined the effect of PICK1 overexpression coexpression is not due to an increase in the whole-cell
on DAT activity. Uptake activity was undetectable in levels of DAT. To test the possibility that the enhance-
mock-transfected cells. Coexpression of PICK1 and ment of transporter activity by PICK1 involves a direct
DAT caused a significant enhancement of DAT uptake interaction between PICK1 and DAT, we examined the
in HEK-293 cells (Figure 4). The total uptake activity effect of PICK1 overexpression on the activity of a DAT
(Vmax) was enhanced by an average of 2-fold in cells mutant lacking the PDZ binding site. We found that the
transfected with DAT and PICK1 when compared to DAT deletion mutant DATW617* displayed a significant
cells transfected with DAT alone (Figures 4A and 4C). decrease in uptake activity compared to wild-type DAT
No significant changes in the affinity of dopamine for (66.7% of wild-type DAT activity; Figure 4C). Importantly,
the transporter were observed under the same condi- PICK1 overexpression was unable to enhance dopa-
tions (Km 5 1.5 6 0.21 mM for cells expressing DAT mine uptake mediated by DATW617* (Figure 4C).
alone versus Km 5 1.6 6 0.16 mM for cells coexpressing The stimulatory effect of PICK1 could result from an
DAT and PICK1), suggesting that changes in the turn- increase in the number of plasma membrane DATs. To
over rate of DAT were unlikely. Radioligand binding ex- address this issue, we performed surface biotinylation
periments using the DAT selective hydrophobic ligand experiments using Sulfo-NHS-SS-biotin. This com-
[3H]CFT indicated that PICK1 overexpression had no pound binds to free amino groups of proteins, and since
it is membrane impermeant, it can be used to distinguisheffect on either the total number of DAT molecules ex-
Association of PICK1 with Monoamine Transporters
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Figure 3. Disruption of the PDZ-Mediated In-
teraction Abolishes the Colocalization and
Cluster Formation between PICK1 and DAT
Double-labeling immunofluorescence from
cells coexpressing PICK1 and wild-type DAT
(A) or mutant transporters lacking the entire
carboxyl terminus (DATL583*) (B), the last
four residues (DATW617*) (C), or the terminal
valine (DATV620*) (D). Lack of colocalization
and clustering formation is also observed in
cells coexpressing the wild-type DAT and the
mutant PICK1/K27AD28A (E).
between cell surface and intracellular proteins. Mem- recruitment of transporters to the plasma membrane or
an interference with the removal of transporters frombrane-bound proteins labeled with Sulfo-NHS-SS-biotin
were isolated with streptavidin beads and analyzed by the cell surface.
Western blot using the anti-DAT antibody. As shown in
Figure 4D, the expression of DAT on the cell membrane Association between DAT and PICK1 In Vivo
To establish the physiological significance of our find-was increased when coexpressed with PICK1 under
conditions in which the total levels of transporter mole- ings in vivo, we examined the cellular distribution of
PICK1 and DAT in cultured mouse midbrain dopaminer-cules remain unchanged. Taken together, these obser-
vations suggest that a PDZ-mediated interaction en- gic neurons by immunocytochemistry and confocal mi-
croscopy. DAT immunoreactivity was observed in z5%hances the uptake activity of DAT by increasing the
number of functional transporters at the cell membrane. of the total neurons (data not shown). In these cells,
DAT showed a punctate staining pattern along neuronalFurther studies will be required to determine whether
the PICK1-DAT interaction results in a more efficient processes (Figure 5). Double staining with DAT and
Neuron
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Figure 4. PICK1 Overexpression Enhances
DAT Activity and Cell Membrane Expression
in HEK-293 Cells
(A) [3H]DA uptake experiments in cells trans-
fected with DAT alone or DAT and PICK1.
(B) PICK1 overexpression does not alter the
total levels of DAT. Binding experiments were
carried out using 20 nM of [3H]CFT and in-
creasing concentrations of cold CFT ranging
from 10 pM to 10 mM.
(C) PICK1 overexpression increases uptake
activity of the wild-type DAT but does not
affect the uptake activity of a truncated trans-
porter lacking the last four residues. Results
are expressed as pmol/min/well. The data
represents the means 6 SEM of five different
experiments (*p , 0.001, paired Student’s t
test).
(D) PICK1 overexpression increases the cell
membrane expression of DAT. Cell surface
biotinylation experiments were performed in
HEK-293 cells expressing DAT or DAT and
PICK1. After biotinylation, each sample was
divided into two aliquots. Biotinylated pro-
teins were isolated with UltraLink Immobi-
lized NeutrAvidin, whereas total DAT was
immunoprecipitated with the anti-DAT anti-
body. Samples were analyzed by Western
blotting with the anti-DAT antibody. Results
shown are representative of three separate
experiments.
PICK1 antibodies revealed extensive overlap of DAT and sent DAT (Figure 5E). Likewise, immunoprecipitation of
DAT from wild-type mouse striatum resulted in the co-PICK1 immunostaining along the neural processes in
a clustering distribution pattern (Figure 5A). A similar precipitation of PICK1, and no signal was detected from
tissue derived from DAT knockout mice (Figure 5E).distribution pattern was found when using the extracel-
lular domain DAT antibody prior to permeabilization (Fig-
ure 5B), thus demonstrating the cell membrane localiza- Disruption of the PDZ Binding Site in DAT Impairs
the Distribution of the Transporter in Neuronstion of these clusters. In addition, PICK1 and DAT
colocalize in dopamine terminal–rich striatal slices, To assess the role of the terminal PDZ interaction site
in DAT trafficking and targeting, we transfected dopa-where both proteins were found at presynaptic terminals
(data not shown). minergic neurons in culture with an HA-tagged DAT mu-
tant lacking the last four residues. As a control, we trans-We further characterized the cellular localization of the
DAT-PICK1 clusters in midbrain neurons using axonal fected neurons with the full-length DAT tagged with the
HA epitope also at the amino terminus. Double stainingmolecular markers. DAT colocalized along the pro-
cesses with the vesicular monoamine transporter-2 immunofluorescence with the HA and PICK1 antibodies
was then used to examine the distribution of the exoge-(VMAT-2; Figure 5C), a synaptic vesicle protein exclu-
sively expressed in monoaminergic neurons (Nirenberg nous full-length and mutant transporters and the endog-
enous PICK1. As shown in Figure 6A, the full-lengthet al., 1997). DAT also colocalized with the presynaptic
protein synapsin (De Camilli et al., 1983) at axonal pro- HA-DAT was detected in clusters along the neuronal
processes where it colocalized with PICK1. In contrast,cesses of some midbrain neurons (Figure 5D). As ex-
pected, since synapsin is a ubiquitous protein, most the HA-tagged mutant transporter was not detected
along the neuronal projections but rather confined toneurons stained positive for synapsin (data not shown),
and only a small fraction showed double staining for the neuronal soma (Figure 6B). These results strongly
suggest that the terminal PDZ binding site of DAT issynapsin and DAT (Figure 5 D). These data indicate that
the DAT clusters observed along the neuronal processes essential for the proper targeting of the transporter in
neurons.of midbrain dopaminergic neurons are associated with
presynaptic structures.
We finally tested whether the endogenous DAT and Enhanced DAT Activity by PICK1 in Immortalized
Dopaminergic NeuronsPICK1 form a protein complex using a coimmunoprecipita-
tion assay from brain tissue. In a membrane preparation To explore the possibility that the upregulation of DAT
activity by PICK1 overexpression observed in HEK-293from mouse striatum, which is enriched in DAT-containing
dopaminergic terminals, immunoprecipitation with an cells is physiologically relevant, we tested whether
PICK1 could regulate the uptake activity of DAT in neu-anti-PICK1 antibody resulted in coprecipitation of an
z80 kDa protein immunoreactive to the DAT antibody rons. Overexpression of PICK1 in cultured mouse mid-
brain primary neurons in fact did increase transporter(Figure 5E). Striatal membrane preparations from DAT
knockout mice were used to confirm that the observed activity in cultures transfected with DAT and PICK1
when compared with cultures transfected with DATDAT-immunoreactive 80 kDa protein did, in fact, repre-
Association of PICK1 with Monoamine Transporters
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Figure 5. Association of Endogenous PICK1
and DAT
(A and B) Immunocytochemical localization
of DAT and PICK1 in cultured dopaminergic
neurons. Double-labeling immunofluores-
cence of a neuronal process from a dopamin-
ergic neuron stained with antibodies to PICK1
and an anti-DAT antibody raised against the
intracellular amino terminus of DAT (A). A dif-
ferent DAT antibody that recognizes the sec-
ond extracellular loop of DAT was used to
show that the surface DAT colocalizes with
PICK1 (B). PICK1 is visualized by FITC sec-
ondary antibody, whereas DAT is visualized
by Texas red secondary antibody.
(C and D) Double immunostaining of midbrain
nerons in culture with the anti-DAT antibody
and the antibodies against the synaptic pro-
teins VMAT-2 (C) and synapsin (D).
(E) DAT and PICK1 coimmunoprecipitate
from brain tissue. Crude membrane prepara-
tions from the striatum of wild-type (DAT1/1)
or knockout (DAT2/2) mice were solubilized
with digitonin, and the proteins were immuno-
precipitated with the anti-PICK1 antibody
(left) or the anti-DAT antibody (right) and the
blots revealed by DAT and PICK1 antibodies,
respectively.
alone (data not shown). However, the rarity of DA neu- shown). The deletion mutant DATW617* exhibited little
uptake activity when transfected either alone or withrons in culture, the low transfection efficiency, the high
uptake background, and the heterogeneity of the cell PICK1, suggesting that the PDZ binding site of DAT
is critical for the proper functional expression of thepopulation in primary neuron cultures complicate the
interpretation of this observation. For this reason, we transporter in these cells. Analysis of plasma membrane
transporter by biotinylation showed an increase in HA-used as a model system a line of immortalized dopamine
neurons (1RB3AN27) derived from fetal rat mesenceph- tagged DAT expression at the cell surface when PICK1
was overexpressed (Figure 7B). As observed in primaryalon (Clarkson et al., 1999). In the presence of dibutyryl
cAMP, these cells differentiate into neurons that pro- midbrain cultures, PICK1 and the HA-tagged DAT colo-
calized in clusters along neuronal processes when coex-duce and synthesize dopamine. This dopaminergic cell
line has been extensively characterized and used in pressed in 1RB3AN27 neurons (Figure 7C). These data
are consistent with the effect of PICK1 observed in HEK-transplant therapy in animal models of Parkinson’s dis-
ease (Clarkson et al., 1998). These cells did not exhibit 293 cells and suggest that this interaction plays an im-
portant role in the control of transporter activity in vivo.detectable [3H]DA uptake activity (data not shown).
In differentiated cells transfected with HA-tagged DAT
and PICK1, the uptake activity increased about 50% as Interaction between PICK1 and NET
Having demonstrated the specific association betweencompared with cells transfected with HA-tagged DAT
alone (Figure 7A). PICK1 overexpression did not induce DAT and PICK1, we next explored whether other mem-
bers of the monoamine transporter family may interactuptake activity in mock-transfected cells (data not
Neuron
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Figure 6. Requirement of the PDZ Domain
Binding Site of DAT in the Axonal Targeting
of DAT
(A) Colocalization of the exogenous HA-DAT
with PICK1 along neuronal processes. HA-
tagged DAT cDNA was transfected into
midbrain primary neurons. Yellow arrows in-
dicate clusters where HA-DAT and PICK1
colocalize.
(B) Loss of colocalization of HA-DAT deletion
mutant with PICK1 at the neuronal process
(white arrows). HA-tagged DAT mutant lack-
ing the last four residues was transfected into
midbrain primary neurons. Red arrows indi-
cate the expression of this construct in the
neuronal soma.
with PICK1. The NET shares z78% amino acid identity served in yeast (Figure 8A). Consistent with the results
obtained using DAT, deletion of the last three residueswith DAT (Pacholczyk et al., 1991; Giros et al., 1991;
Kilty et al., 1991; Shimada et al., 1991; Usdin et al., in NET completely abolished the interaction with PICK1
in yeast (Figure 8A). Using the same strategy, we also1991; Giros et al., 1992; Vandenbergh et al., 1992), and
contains a carboxy-terminal sequence (LAI) reminiscent detected an interaction between the SERT tail and
PICK1 in the yeast assay (Figure 8A). This interaction,of a class II PDZ binding site, which represents an excel-
lent candidate for interacting with PICK1. To test this however, was much weaker than the PICK1-DAT or the
PICK1-NET interactions, which might not be unexpectedhypothesis, we generated a bait construct encoding the
carboxy-terminal region of NET (NETC) and tested for since SERT does not contain an ideal Class II PDZ do-
main targeting sequence (NAV) at the end of its carboxylinteraction with PICK1 in the yeast two-hybrid system.
A strong interaction between PICK1 and NETC was ob- terminus.
Figure 7. PICK1 Enhances DAT Activity in
Immortalized Dopamine Neurons
(A) [3H]DA uptake experiments in differenti-
ated 1RB3AN27 cells transfectd with HA-
DAT, HA-DAT and PICK1, HA-DATW617*, or
HA-DATW617* and PICK1 cDNAs. Cells were
differentiated in the presence of 2 mM dibu-
tyryl cAMP and transfected using the Effec-
tene system.
(B) PICK1 overexpression increases cell sur-
face expression of DAT without altering the
total levels of the transporter. Biotinylation
experiments were performed as described in
the Experimental Procedures.
(C) DAT and PICK1 colocalize in a cluster pat-
tern along the neuronal process. HA-DAT was
visualized with an anti-HA rhodamine-conju-
gated antibody (red), whereas PICK1 was
stained with a rabbit PICK1 antibody followed
by an anti-rabbit FITC-conjugated antibody
(green).
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Figure 8. Association of PICK1 and NET
(A) Specific association between PICK1 and
the carboxy terminus of NET, SERT, and
GLYT in the yeast two-hybrid assay. Yeast
strain pG694a was cotransformed with plas-
mids encoding the GAL4 DNA binding do-
main fused to the tail of NET, SERT, or GLYT
or the GAL4 activation domain fused to
PICK1. Protein–protein interaction was as-
sayed by growing the yeast on selective me-
dium lacking leucine, tryptophan, and ade-
nine (2L2W2A). The number of pluses
indicates the strength of the protein–protein
interaction, whereas a minus indicates no in-
teraction. Mutational analysis of the carboxy-
terminal sequence of NET reveals the impor-
tance of the terminal sequence LAI for the
binding to PICK1.
(B) Coimmunoprecipitation of PICK1 and NET
in HEK-293 cells. Proteins were transiently
expressed in HEK-293 cells by transfecting
NET (lane 1), NET and PICK1 (lanes 2 and
4), or PICK1 (lane 3) constructs. Whole-cell
lysates were used for immunoprecipitation
with the anti-PICK1 antibody (left) or the anti-
NET antibody (right). Immunoprecipitates
were separated on 8% SDS-PAGE, blotted
onto nitrocellulose membranes, and probed
with specific antibodies as indicated.
(C) HEK-293 cells transfected with PICK1
cDNA were labeled with a rabbit anti-PICK1
antibody and a FITC anti-rabbit secondary
antibody.
(D) Cells expressing NET alone were labeled
with a mouse anti-NET antibody and a Texas
red anti-mouse secondary antibody.
(E) Coexpression of PICK1 and NET results
in colocalization and cluster formation as re-
vealed by double-labeling immunofluores-
cence.
(F) PICK1 and NET colocalize in noradrener-
gic neurons in culture. Noradrenergic neu-
rons were prepared from the locus coeruleus
of 14-day-old embryonic mice and stained
with antibodies to PICK1 and an anti-NET an-
tibody raised against the intracellular amino
terminus of NET. PICK1 is visualized by FITC
secondary antibody, whereas NET is visual-
ized by Texas red secondary antibody.
To examine the selectivity of the interaction between interact with PICK1. GLYT belongs to the same family
of Na1/Cl2-dependent plasma membrane transportersPICK1 and monoamine transporters, we generated a
bait construct encoding the carboxy-terminal region of that also includes DAT, NET, and SERT. PICK1 failed to
activate reporter expression in the presence of the GLYTthe glycine transporter (GLYT) and tested its ability to
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tail, despite the fact that this protein contains a carboxy- amine transporters, little is known about the extrinsic
terminal sequence (SRI) that closely resembles a class molecular factors that govern these processes. The
I PDZ binding site (Figure 8A). Taken together, these identification of the PDZ domain–containing protein
results suggest that PICK1 interacts with monoamine PICK1 with the use of the yeast two-hybrid system repre-
transporters in a rather selective manner through the sents an initial step in our attempt to elucidate the regu-
binding between the PDZ motif in PICK1 and the `-X-` latory machinery of transporter function. Our data dem-
sequence present at the carboxyl termini of monoamine onstrate that both DAT and NET contain a functional
transporters. Thus, perhaps the presence of a class I PDZ binding motif that is required for the interaction
PDZ binding sequence in other members of the trans- with PICK1. This PDZ-mediated interaction is essential
porter family suggests that other PDZ domain– for the colocalization and clustering of DAT and NET in
containing proteins might also associate with these mammalian cells. Moreover, such interaction signifi-
transporters. cantly enhances the dopamine uptake activity of DAT
Based on the strong interaction of NET and PICK1 through a mechanism involving an increase in the num-
in yeast, we investigated their potential association in ber of functional transporters at the plasma membrane,
mammalian cells and in neurons in culture. In HEK-293 suggesting that PICK1 may facilitate transporter activity
cells transfected with cDNAs encoding both proteins, by clustering more transporter molecules at the cell sur-
PICK1 coimmunoprecipitated with NET regardless of face. Furthermore, three lines of evidence support the
which antibody was used for the immunoprecipitation notion that PICK1 and DAT form a functional protein
(Figure 8B). When expressed alone in HEK-293 cells, complex in vivo. First, a direct physical interaction be-
PICK1 displayed a diffuse intracellular distribution (Fig- tween PICK1 and DAT was demonstrated by coimmuno-
ures 2A and 8C), whereas NET was localized predomi- precipitation experiments from mice striatal membranes.
nantly throughout the plasma membrane (Figure 8D). Second, PICK1 colocalizes with DAT in cultured dopa-
However, coexpression of PICK1 and NET resulted in minergic neurons and in striatal brain slices. Finally,
a striking colocalization pattern and the formation of deletion of the PDZ binding site in DAT impairs the tar-
clusters similar to those seen in cells coexpressing DAT geting of the transporter to neuronal processes. These
and PICK1 (Figure 8E). The association of PICK1 and results point to the physiological relevance for the func-
NET was further investigated in a native setting. Double tional interaction of PICK1 and DAT proteins.
labeling of cultured neurons of the noradrenergic locus The PDZ domain–mediated protein–protein interac-
coeruleus for NET and PICK1 reveals an extensive colo- tion involves the PDZ motif and a consensus sequence,
calization of both proteins in a clustering distribution termed the PDZ binding site, located at the extreme
along the neuronal processes (Figure 8F). Taken to- carboxyl terminus of target proteins (reviewed by Fan-
gether, these data demonstrate the specific interaction ning and Anderson, 1999). Both motifs are essential,
between the synaptic protein PICK1 and members of since disruption of either the PDZ motif or the PDZ
the monoamine plasma membrane transporter family. binding site results in loss of interaction (Staudinger et
al., 1996; Xia et al., 1999; this study). While the majority of
Discussion the PDZ domain–interacting proteins contain the class I
consensus sequence, S/T-X-V/I, the PDZ binding se-
In this study, we demonstrated that the PDZ domain– quences in the monoamine transporters are of the class
containing protein PICK1 interacts with plasma mem- II, `-X-`. Disruption of this sequence in DAT completely
brane monoamine neurotransmitter transporters both in abolishes the physical as well as the functional interac-
vitro and in vivo. We show that this interaction plays a tion with PICK1.
functional role by enhancing DAT uptake activity in both During the last decade, a large number of studies have
mammalian cells and neurons. Mutational analysis indi-
established the importance of PDZ domain–mediated
cates that both the PDZ motif in PICK1 and a PDZ bind-
interactions in the localization and compartmentaliza-
ing site at the carboxyl terminus of monoamine trans-
tion of several classes of ion channels, neurotransmitterporters are required for the physical and functional
receptors, and effector proteins (Sheng and Wyszynski,interactions between these proteins. In addition, disrup-
1997; Kornau et al., 1997). NMDA receptors, for example,tion of the PDZ binding site in DAT impairs the targeting
colocalize specifically at the postsynaptic cell mem-of the transporter in neurons. These results, which pro-
brane with several PDZ domain–containing proteins, in-vide a demonstration that a protein in the PDZ domain
cluding members of the PSD-95 family (O’Brien, et al.,family interacts with monoamine plasma membrane
1998). In addition, several reports have implicated a roletransporters through a PDZ motif–dependent mecha-
for PDZ-mediated interactions in the regulation of Gnism, add transporters to the growing list of synaptic
protein–coupled receptors (Hall et al., 1998; Manivet etproteins that are regulated by PDZ-mediated interac-
al., 2000). In Drosophila, the PDZ domain–containingtions. Such interactions may contribute to the targeting,
protein InaD serves as an adaptor protein that recruitstrafficking, and/or activity-dependent relocalization of
several signaling components into a macromoleculartransporters in nerve terminals, which could significantly
complex (Tsunoda et al., 1997). Recently, members ofmodulate the function and plasticity of the nervous
the Eph family of tyrosine kinase receptors and theirsystem.
ligands were found to bind and synaptically colocalize
with a subset of PDZ domain–containing proteins, in-Monoamine Transporters: A Novel Class of PDZ
cluding PICK1 (Torres et al., 1998). Our discovery of aMotif–Interacting Proteins
PDZ domain–mediated interaction between PICK1 andDespite extensive efforts to elucidate the regulatory
mechanisms associated with plasma membrane mono- DAT as well as PICK1 and NET identifies monoamine
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Experimental Procedurestransporters as a novel class of PDZ domain–interacting
proteins.
Yeast Two-Hybrid Screening and cDNA ConstructsRecent evidence suggests that dopamine transport- Yeast two-hybrid screening was performed using the pG694a strain
ers are targeted to specialized plasma membranes as harboring the reporter genes HIS3 and Ade under the control of
well as intracellular stores in neurons (Nirenberg et al., upstream Gal4 binding sites. The entire carboxy-terminal domain
of the human DAT (amino acids 578–620) was amplified by PCR1995, 1996; Hersch et al., 1997; Pickel and Chan, 1999).
with specific primers containing EcoRI and SalI restriction sites. TheFurthermore, monoamine transporters undergo rapid in-
EcoRI and SalI fragment was fused to the GAL4 DNA binding domainternalization in response to PKC activation (Qian et al.,
of pAS2-1 and verified by sequencing. This fusion construct was
1997; Melikian and Buckley, 1999; Daniels and Amara, used to screen 2 3 107 clones of a human brain cDNA library on
1999) through a process that resembles the clathrin- agar plates lacking leucine, tryptophan, and histidine. Positive colo-
nies were reselected on adenine-free media (2L2W2A). DNA frommediated and dynamin-dependent internalization of G
positive clones were isolated from yeast colonies, transformed intoprotein–coupled receptors (Ferguson et al., 1998). It is
HB101 bacteria by electroporation, isolated from bacteria, and ana-tempting to speculate that PDZ-containing proteins,
lyzed by enzyme restriction and automated DNA sequencing.
such as PICK1, may be involved in the targeting, anchor- The carboxy-terminal regions of NET (amino acids 575–617), SERT
ing, and/or regulated trafficking of presynaptic mono- (amino acids 594–630), and GLYT (amino acids 600–638) and the
amino terminus of DAT (amino acids 1–60) were amplified by PCRamine transporters.
using specific primers and fused in frame with the GAL4 binding
domain of pAS2-1. Deletion mutants of the DAT and NET carboxyl
termini were also generated by PCR and subcloned into pAS2-1.Potential Role of the PICK1-DAT Interaction
All DNA fragments were verified by automated sequencing. These
PICK1 was originally identified by its interaction with constructs were cotransformed with pGAD10-PICK1 into pG694a
PKCa in a yeast two hybrid-screening (Staudinger et al., yeast and grown on adenine-free media. Specific interactions be-
tween each fragment and PICK1 were indicated by the growth of1995). It has been demonstrated that PKC activation
yeast clones on leucine-, tryptophan-, and adenine-free media.downregulates the uptake activity of dopamine trans-
porters via internalization in mammalian cell lines (Dan-
Antibodiesiels and Amara, 1999; Melikian and Buckley, 1999). Thus,
The polyclonal antibody raised against PICK1 has been described
another potential role of the PICK1-DAT interaction previously (Staudinger et al., 1995). The anti-DAT rat monoclonal
could be to cross-link these two proteins at specific antibody raised against the intracellular amino terminus of DAT was
from Chemicon, whereas the anti-DAT antibody raised against thepresynaptic domains. Such cross-linking may be impor-
second extracellular loop of DAT has been described previouslytant in the efficient PKC regulation of DAT, whose activity
(Ciliax et al., 1995). The anti-NET mouse monoclonal antibody wasis crucial in the maintenance of physiological levels of
obtained from Molecular Probes. Antibodies against VMAT-2 and
dopamine and the complex orchestrating of dopamine synapsin were purchased from Chemicon. Horseradish peroxidase–
signaling (Jones et al., 1998a). labeled secondary antibodies were purchased from Amersham.
It is intriguing that PICK1 is widely expressed in many FITC- and Texas red–conjugated secondary antibodies were from
the Jackson Laboratory, whereas the rhodamine-conjugated anti-tissues, including heart, lung, muscle, kidney, and brain
HA antibody was purchased from Roche.(Xia et al., 1999). Thus, PICK1 may function as a general
adaptor/docking/scaffold molecule by binding to and or-
DNA Constructs, HEK-293 Cell Culture, and Transfectionsganizing the subcellular localization of a variety of mem-
The coding sequence corresponding to the human DAT, NET, and
brane proteins containing PDZ recognition sequences. PICK1 cDNAs were subcloned into the mammalian expression vec-
The findings that PICK1 colocalizes with AMPA receptors tor pcDNA3 (Invitrogen). Mutations of the carboxy-terminal domain
of DAT were carried out by PCR, and DNAs encoding the mutant(Xia et al., 1999), tyrosine kinase receptors (Torres et al.,
transporters were subcloned into pcDNA3. HEK-293 cells were1998), and now monoamine transporters (this study) in
grown to 60%–80% confluency in 100 mm tissue culture dishes andcentral neurons support this possibility. Since PICK1 inter-
transiently transfected using Ca2PO4 precipitation with 1–10 mg ofacts with AMPA receptors postsynaptically, and with total DNA. Cells were incubated with the Ca2PO4-DNA mixture at
dopamine transporters presynaptically, it could poten- 378C for 16 hr, followed by 48 hr recovery in MEM supplemented
tially coordinate the neural activity-dependent modula- with 10% fetal bovine serum, 50 U/ml of penicillin, and 50 U/ml of
streptomycin. Subsequent experiments were performed 48–72 hrtion of multiple synaptic inputs converging at a common
after transfection.postsynaptic cell. Such interacting circuits are widely
present in the brain—for example, in striatal neurons
Neuronal Cultures, Immortalized Dopamine Neurons,receiving both glutamatergic and dopaminergic inputs
and Transfections
simultaneously (Berke and Hyman, 2000). Primary cultures of neurons were prepared from the midbrain (for
Abnormal levels of monoamine neurotransmitters dopaminergic neurons) or from locus coeruleus (for noradrenergic
neurons) of 14-day-old mice embryos. The tissue was digested inhave been associated with many psychiatric and neuro-
MEM containing 0.25% trypsin and 20 mg/ml DNase at 378C for 20logical disorders. Monoamine neurotransmitter trans-
min and mechanically triturated with a fire-polished pasteur pipette.porters are important targets of prescribed drugs to
The dissociated neurons were centrifuged at 450 3 g, resuspended
treat such psychiatric conditions as depression, obses- in growth medium (MEM supplemented with 10% FBS, 0.5% glu-
sive–compulsive disorder, and attention deficit–hyper- cose, 50 U/ml penicillin, and 50 U/ml streptomycin), and plated in
collagen-coated 35 mm confocal dishes (Mattek). The immortalizedactivity disorder. Identification of new proteins that as-
dopaminergic cell line 1RB3AN27 was kindly provided by Dr. K.sociate with monoamine transporters will advance our
Prasad (University of Colorado Health Sciences Center). Cells wereunderstanding of the regulatory mechanisms associated
grown in RPMI medium supplemented with 10% FBS and 1% peni-
with the trafficking, targeting, and function of transport- cillin and streptomycin and differentiated in the presence of 2 mM
ers and ultimately might provide new therapeutic strate- dibutyryl cAMP. The neurons were grown at 378C for 3–5 days before
immunostaining experiments. Transfections were performed in dif-gies against these various psychiatric conditions.
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ferentiated neurons using the Effectene system (Qiagen) according hanced chemiluminescence system (Amersham). A similar protocol
was used for immunoprecipitation experiments in transfected HEK-to the manufacturer’s recommendations.
293 cells or immortalized dopamine neurons.
Immunocytochemistry and Confocal Microscopy
For immunostaining experiments, transiently transfected HEK-293 Cell Surface Biotinylation
cells grown on glass coverslips placed in six-well dishes at a density Confluent monolayers of HEK-293 cells or immortalized dopamine
of 5 3 105 cells/well, 3- to 5-day-old transfected or nontransfected neurons were washed three times with PBS and then incubated
midbrain neurons in culture, or transfected immortalized dopamine with gentle agitation for 30 min at 48C with 1 ml of 1 mg/ml Sulfo-
neurons were fixed with 4% paraformaldehyde. After three washes NHS-SS-biotin in PBS supplemented with 0.1 mM HEPES (pH 8.0).
with PBS, cells were permeabilized in PBS containing 0.1% Triton The reaction was quenched by incubating the cells for an additional
X-100 for 10 min and incubated in blocking solution (PBS, 1% bovine 10 min with 50 mM glycine in PBS. The cells were then washed
serum albumin, 5% goat serum) for 1 hr. Cells were incubated with three times in PBS and incubated in RIPA buffer at 48C for 1 hr.
primary antibodies (rabbit anti-PICK1, 1:1000; rat anti-DAT, 1:1000; Each sample was divided into two aliquots. One aliquot was used
mouse anti-NET,1:1000; mouse anti-synapsin,1:200; rabbit anti- for isolation of biotinylated proteins with UltraLink Immobilized
VMAT-2, 1:500; mouse anti-HA, 1:200) for 1 hr at room temperature NeutrAvidin (Pierce). The second aliquot was used to determine the
followed by incubation with secondary antibodies (FITC-conjugated total DAT by immunoprecipitation with the anti-DAT antibody. Sam-
anti-rabbit IgG, Texas red–conjugated anti-rat IgG, or Texas red– ples were analyzed by Western blotting with the anti-DAT antibody.
conjugated anti-mouse IgG; 1:200). For immunostaining with the
extracellular anti-DAT antibody, HEK-293 cells or neurons in culture Acknowledgments
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